Background Image
Previous Page  27 / 30 Next Page
Information
Show Menu
Previous Page 27 / 30 Next Page
Page Background

27

treatment in acuteoptic neuritis. Neurology

2005;64:804-10.

20.

Mandler RN, Ahmed W, Dencoff JE. Devic’s

neuromyelitis optica: a prospective study of

seven patients treated with prednisone and

azathioprine. Neurology 1998;51:1219-20.

21.

Watanabe S, Misu T, Miyazawa I, Nakashima I,

Shiga Y, Fujihara K, et al. Low-dose

corticosteroids reduce relapses in neuromyelitis

optica: a retrospective analysis. Mult Scler

2007;13:968-74.

22.

Weinstock-Guttman B, Ramanathan M, Lincoff

N, Napoli SQ, Sharma J, Feichter J, et al. Study

of mitoxantrone for the treatment of recurrent

neuromyelitis optica (Devic disease). Arch

Neurol 2006;63:957-63.

23.

Bomprezzi R, Postevka E, Campagnolo D,

Vollmer TL. A review of cases of neuromyelitis

optica. Neurologist 2011;17:98-104.

24.

Cree BA, Lamb S, Morgan K, Chen A, Waubant

E, Genain C. An open label study of the effects

of

rituximab

in

neuromyelitis

optica.

Neurology. 2005;64:1270-2.

25.

Jacob A, Weinshenker BG, Violich I, McLinskey

N, Krupp L, Fox RJ, et al. Treatment of

neuromyelitis

optica

with

rituximab:

retrospective analysis of 25 patients. Arch

Neurol. 2008;65:1443-8.